Agilent Technologies (NYSE:A) Price Target Raised to $180.00

Agilent Technologies (NYSE:A) had its target price raised by Bank of America from $155.00 to $180.00 in a research note published on Thursday morning,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock.

A has been the topic of several other research reports. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. Royal Bank Of Canada lifted their target price on Agilent Technologies from $155.00 to $185.00 and gave the company an “outperform” rating in a research note on Thursday. Jefferies Financial Group started coverage on Agilent Technologies in a research note on Thursday, July 9th. They set a “hold” rating and a $135.00 price target on the stock. Sanford C. Bernstein raised their price target on Agilent Technologies from $155.00 to $180.00 and gave the company an “outperform” rating in a report on Thursday. Finally, TD Cowen lifted their price objective on Agilent Technologies from $155.00 to $180.00 and gave the stock a “buy” rating in a research report on Thursday. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $170.33.

Agilent Technologies Trading Down 2.0%

A opened at $154.47 on Thursday. Agilent Technologies has a 1-year low of $108.35 and a 1-year high of $163.75. The stock has a market capitalization of $43.63 billion, a PE ratio of 30.41, a PEG ratio of 2.65 and a beta of 1.25. The company has a current ratio of 2.05, a quick ratio of 1.62 and a debt-to-equity ratio of 0.50. The firm has a 50-day moving average price of $140.30 and a two-hundred day moving average price of $127.04.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The company had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. During the same period in the prior year, the business earned $1.37 earnings per share. Agilent Technologies’s quarterly revenue was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, equities analysts anticipate that Agilent Technologies will post 6.2 earnings per share for the current fiscal year.

Institutional Trading of Agilent Technologies

Institutional investors and hedge funds have recently made changes to their positions in the business. SHP Wealth Management bought a new position in shares of Agilent Technologies in the 4th quarter worth $26,000. Core Wealth Advisors LLC acquired a new stake in shares of Agilent Technologies during the fourth quarter worth $26,000. Navalign LLC bought a new stake in Agilent Technologies in the fourth quarter valued at about $27,000. Markowski Investments acquired a new position in Agilent Technologies in the second quarter valued at about $27,000. Finally, MV Capital Management Inc. acquired a new position in Agilent Technologies in the fourth quarter valued at about $28,000.

Agilent Technologies News Roundup

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
• Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
• Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.